Biosapien
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $37M
Investors
- 11
About Biosapien
, based in the US, specializes in innovative drug delivery systems tailored for cancer treatment, aiming to minimize side effects while maximizing therapeutic effectiveness. Founded in 2018 and headquartered in San Diego, California, Biosapien, Inc. focuses on developing advanced medical technologies. In July 2025, Biosapien, Inc. Biosapien's core product, MediChip™, is a sophisticated drug delivery system aimed at directly targeting tumors, reducing side effects associated with traditional chemotherapy. This technology enables a more precise medication delivery, potentially improving treatment outcomes for cancer patients. MediChip™ has received global patent protection, facilitating distribution in markets including the US, UK, Europe, Australia, and China, serving a broad spectrum of healthcare providers and patients. The revenue model for Biosapien revolves around the distribution of MediChip™ to healthcare institutions specializing in oncology. Their sales approach includes direct transactions with hospitals and clinics, focusing on personalized treatment plans and potential partnerships that may include subscription services for ongoing support related to the MediChip™ technology. Contracts with healthcare providers are likely to reflect the importance of their product in cancer treatment protocols.
Who invested in Biosapien
11 investors across 3 rounds
See all investors in Biosapien
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biosapien
Who invested in Biosapien?
Biosapien has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biosapien raised?
Biosapien has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Biosapien last raise money?
Biosapien's most recent round on record is a Series A, in Nov 2022.
What does Biosapien do?
, based in the US, specializes in innovative drug delivery systems tailored for cancer treatment, aiming to minimize side effects while maximizing therapeutic effectiveness.
Where is Biosapien headquartered?
Biosapien is headquartered in San Diego, US.
Which VCs invest in companies like Biosapien?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Biosapien's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Biosapien? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.